Nuwellis Inc vs Global X SuperDividend ETF — how do they compare? Nuwellis Inc trades at $2.95 (market cap $1.09M), while Global X SuperDividend ETF trades at $24.87. The key difference: Global X SuperDividend ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | SDIV | |
|---|---|---|
Market Cap | $1.09M | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $527.46 | $26.34 |
52-Week Low | $2.80 | $22.90 |
Enterprise Value | -$722.58K | — |
Trailing returns across standard periods
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →SDIV is an ETF that invests in 100 of the highest dividend-yielding equity securities in the world. The fund seeks to provide a high level of income to investors by selecting companies from both developed and emerging markets that have historically provided high dividend yields. By diversifying globally, SDIV aims to mitigate risks associated with focusing on a single country, while offering monthly distributions to its shareholders.
Read more on SDIV →